These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 15164288)
1. The tall-cell variant of papillary thyroid carcinoma: a multivariate analysis of clinical risk factors. Machens A; Holzhausen HJ; Lautenschläger C; Dralle H Langenbecks Arch Surg; 2004 Aug; 389(4):278-82. PubMed ID: 15164288 [TBL] [Abstract][Full Text] [Related]
2. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens. Solomon A; Gupta PK; LiVolsi VA; Baloch ZW Diagn Cytopathol; 2002 Sep; 27(3):143-8. PubMed ID: 12203860 [TBL] [Abstract][Full Text] [Related]
3. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients. Kazaure HS; Roman SA; Sosa JA Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195 [TBL] [Abstract][Full Text] [Related]
4. Tall cell variant of papillary thyroid carcinoma: a population-based study in Iceland. Axelsson TA; Hrafnkelsson J; Olafsdottir EJ; Jonasson JG Thyroid; 2015 Feb; 25(2):216-20. PubMed ID: 25322334 [TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of papillary thyroid carcinoma with tall-cell features. Ganly I; Ibrahimpasic T; Rivera M; Nixon I; Palmer F; Patel SG; Tuttle RM; Shah JP; Ghossein R Thyroid; 2014 Apr; 24(4):662-70. PubMed ID: 24262069 [TBL] [Abstract][Full Text] [Related]
6. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis. Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884 [TBL] [Abstract][Full Text] [Related]
8. Risk factors of distant metastasis in the follicular variant of papillary thyroid carcinoma. Li YR; Chen ST; Hseuh C; Chao TC; Ho TY; Lin JD J Formos Med Assoc; 2016 Aug; 115(8):665-71. PubMed ID: 26239193 [TBL] [Abstract][Full Text] [Related]
9. Clinical features and outcome of the tall cell variant of papillary thyroid carcinoma. Leung AK; Chow SM; Law SC Laryngoscope; 2008 Jan; 118(1):32-8. PubMed ID: 18025951 [TBL] [Abstract][Full Text] [Related]
10. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients. Gunalp B; Okuyucu K; Ince S; Ayan A; Alagoz E Hell J Nucl Med; 2017; 20(2):122-127. PubMed ID: 28697188 [TBL] [Abstract][Full Text] [Related]
11. Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival. Morris LG; Shaha AR; Tuttle RM; Sikora AG; Ganly I Thyroid; 2010 Feb; 20(2):153-8. PubMed ID: 20151822 [TBL] [Abstract][Full Text] [Related]
12. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma. Okuyucu K; Alagoz E; Ince S; Arslan N Endokrynol Pol; 2017; 68(6):623-630. PubMed ID: 29022644 [TBL] [Abstract][Full Text] [Related]
13. Tall Cell Variant Papillary Thyroid Carcinoma in Saudi Patients: A clinicopathological and Outcomes Analysis. Al-Qahtani KH; Tunio MA; Al Asiri M; Bayoumi Y; Alshehri WA; Aljohani NJ; Ali AA; Fatani H Saudi Med J; 2016 Nov; 37(11):1220-1224. PubMed ID: 27761560 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of the Proportion of Tall Cell Components in Papillary Thyroid Carcinoma. Ito Y; Hirokawa M; Miyauchi A; Higashiyama T; Kihara M; Miya A World J Surg; 2017 Mar; 41(3):742-747. PubMed ID: 27807709 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma. Michels JJ; Jacques M; Henry-Amar M; Bardet S Hum Pathol; 2007 Feb; 38(2):212-9. PubMed ID: 17097131 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: comparison with classic variant of papillary thyroid carcinoma. Okuyucu K; Alagoz E; Arslan N; Emer O; Ince S; Deveci S; Ayan A; Taslipinar A; Gunalp B; Azal O Nucl Med Commun; 2015 Oct; 36(10):1021-5. PubMed ID: 26225942 [TBL] [Abstract][Full Text] [Related]
20. Age of patients with papillary thyroid carcinoma: is it a key factor in the development of variants? Das DK Gerontology; 2005; 51(3):149-54. PubMed ID: 15832039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]